Connection
Debopam Samanta to Epilepsies, Myoclonic
This is a "connection" page, showing publications Debopam Samanta has written about Epilepsies, Myoclonic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.115 |
|
|
|
-
Samanta D. A comprehensive review of evolving treatment strategies for Dravet syndrome: Insights from randomized trials, meta-analyses, real-world evidence, and emerging therapeutic approaches. Epilepsy Behav. 2025 Jan; 162:110171.
Score: 0.913
-
Samanta D. Changing Landscape of Dravet Syndrome Management: An Overview. Neuropediatrics. 2020 04; 51(2):135-145.
Score: 0.656
-
Samanta D. Cannabidiol: A Review of Clinical Efficacy and Safety in Epilepsy. Pediatr Neurol. 2019 07; 96:24-29.
Score: 0.615
-
Samanta D. Sinus pericranii and myoclonic epilepsy: novel features of 3q29 microdeletion syndrome. Acta Neurol Belg. 2016 Sep; 116(3):363-4.
Score: 0.485
-
Samanta D, Ramakrishnaiah R, Willis E, Frye RE. Myoclonic epilepsy evolved into West syndrome: a patient with a novel de novo KCNQ2 mutation. Acta Neurol Belg. 2015 Sep; 115(3):475-8.
Score: 0.446